Meta AnalysisID 7752
他汀类药物使用与新发糖尿病的性别特异性风险：随机试验的Meta分析
CRD42023413092
To estimate sex differences in statin-related risk of incident diabetes in randomized controlled trials or crossover trials of statins vs. placebo for primary or second prevention of cardiovascular disease. To estimate s
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 7752
- Evidence Id
- 16310
- Core Evidence Id
- 16310
- Source Meta Analysis Id
- 7749
- Herb2 Meta Analysis Id
- HBMA007749
- Crd Id
- CRD42023413092
- Title
- Statin use and sex-specific risk of new-onset diabetes: a meta-analysis of randomized trials
- Review Question
- To estimate sex differences in statin-related risk of incident diabetes in randomized controlled trials or crossover trials of statins vs. placebo for primary or second prevention of cardiovascular disease. To estimate sex differences in statin-related risk of incident diabetes in randomized controlled trials or crossover trials of statins vs. placebo for primary prevention of cardiovascular disease. To estimate sex differences in statin-related risk of incident diabetes in randomized controlled trials or crossover trials of statins vs. placebo for secondary prevention of cardiovascular disease. To estimate sex differences in statin-related risk of incident diabetes in randomized controlled trials or crossover trials of statins vs. placebo for primary prevention of cardiovascular disease stratified by high vs. moderate CVD risk.
- Study Type Included
- RCT, crossover trial
- Condition Being Studied
- Statin-associated diabetes
- Participant
- Adults ≥18 years enrolled in a randomized placebo-controlled trial or crossover trial of statin vs. placebo for primary or secondary prevention of cardiovascular disease.
- Animal
- Human Disease Modelled
- Intervention
- (“statin” or “hydroxymethylglutarylcoenzyme A reductase inhibitors” or “anticholesteremic agents” or “simvastatin” or “rosuvastatin” or “pravastatin” or “atorvastatin” or “fluvastatin” or “cerivastatin” or “pitavastatin” or “lovastatin”)
- Comparator Control
- Placebo
- Main Outcome
- Incident diabetes Measures of effect relative risks, hazard ratios
- Outcome Measure
- Additional Outcome
- Fasting blood glucose Measures of effect Not applicable
- Study Method
- Meta-analysis, Systematic review
- Keyword
- Cardiovascular Diseases; Cross-Over Studies; Diabetes Mellitus; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Randomized Controlled Trials as Topic
- Contact
- Pandora (Luke) Wander [email protected]
- Organisational Affiliation
- VA Puget Sound Health Care System/University of Washington www.uw.edu
- Funding Source
- No funding
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- United States of America
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-05-16
- Registration Date
- 2023-05-27
- Anticipated Start Date
- 2023-05-24
- Anticipated Completion Date
- 2023-09-30
- Title Cn
- 他汀类药物使用与新发糖尿病的性别特异性风险：随机试验的Meta分析
- Title En
- Statin use and sex-specific risk of new-onset diabetes: a meta-analysis of randomized trials
- Bilingual Status
- complete